Physician profile
Peter L Clark
NPI 1396743951
$3,729.48
in general payments reported to CMS, 2019-2025
17 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.64 · 2020: $2,656 · 2021: $87.52 · 2022: $373 · 2023: $271 · 2024: $138 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514 · Entertainment: $12.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.28 |
| Entertainment | $12.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,656.00 | 2020 | |
| Abbvie INC. | $377.41 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $182.30 | 2022-2025 | Veozah |
| Hologic Sales and Service, LLC | $150.84 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $56.70 | 2021-2023 | Balcoltra |
| Boston Scientific Corporation | $52.24 | 2019-2025 | General - Female Sui |
| Pfizer INC. | $51.84 | 2021-2023 | |
| Novo Nordisk INC | $32.51 | 2024 | Wegovy |
| Mayne Pharma Commercial LLC | $23.62 | 2022-2025 | |
| Millicent US INC | $23.17 | 2024 | Intrarosa |
| Mycovia Pharmaceuticals, INC. | $22.09 | 2022 | |
| Sumitomo Pharma America, INC. | $21.37 | 2023 | Myfembree |
| Organon LLC | $19.53 | 2024 | |
| Myovant Sciences INC. | $18.12 | 2021 | |
| Exeltis, USA INC. | $17.01 | 2024 | Slynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $12.78 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Merck Sharp & Dohme LLC | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.